Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)

Stopped Due to poor patient recruitment, a decision was made to terminate this trial.

Conditions

• Crohn's Disease

Interventions

• BIOLOGICAL: Infliximab
• DRUG: AZA
• DRUG: Placebo Prednisolone
• DRUG: Prednisolone
• DRUG: AZA
• BIOLOGICAL: Placebo Infliximab

Sponsor

Merck Sharp & Dohme LLC